ACR updates Appropriateness Criteria

| | Health Imaging | Screening

The American College of Radiology (ACR) has updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition via the latest version of its Appropriateness Criteria.

In the latest version, the ACR updated 23 appropriateness criteria topics and added four new criteria—Pulmonary Hypertension; Renal Transplant Dysfunction; Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva; and Treatment of Stage I T1 Glottic Cancer. ACR Appropriateness Criteria guide physicians when ordering exams and help ensure that patients get the right scan or therapy for the right indication. The criteria have been shown to improve quality, reduce unnecessary exams and lower costs, according to the ACR. 

ACR Appropriateness Criteria provide a tool for more effective clinical decision making to help ensure that imaging is neither over- nor underutilized. The guidelines are developed by expert panels in diagnostic imaging, interventional radiology and radiation oncology. Each panel includes leaders in radiology and other specialties.

Related Content

Rising rates of interval breast cancers have experts calling for more risk-based screenings
Rates of breast cancer diagnosis, death expected to climb in coming decades
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
American College of Radiology announces significant expansion of Lung Cancer Screening Registry
AI beats standard regression models at predicting lung cancer risk

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.